Clinuvel Pharmaceuticals | CUV - Operating Expenses

Stock Price
9.75
Daily Change
-0.08 -0.81%
Monthly
-11.52%
Yearly
-16.02%
Q1 Forecast
9.72

Clinuvel Pharmaceuticals reported AUD20.71M in Operating Expenses for its fiscal semester ending in June of 2024.





Operating Expenses Change Date
Avita Medical AUD 28.02M 1.55M Dec/2025
Medical Developments International AUD 21.61M 11.59M Dec/2025
Mesoblast USD 56.15M 32.57M Jun/2025
Neuren Pharmaceuticals AUD 25.23M 16.54M Dec/2025
Pacific Edge NZD 25.34M 2.03M Dec/2025
Paradigm Biopharmaceuticals AUD 8.49M 2.13M Jun/2025
PYC Therapeutics AUD 33.63M 14.33M Dec/2025
Telix Pharmaceuticals AUD 405.4M 26.29M Dec/2025